Metformin use is associated with low risk of case fatality and disability rates in first-ever stroke patients with type 2 diabetes.
Wen-Jun TuZheng LiuBao-Hua ChaoFeng YanLin MaLei CaoXun-Ming JiLong-De WangPublished in: Therapeutic advances in chronic disease (2022)
The study reveals that metformin use in stroke patients with T2DM results in a less severe stroke and lower fatality and disability rates.